prepforyou

[prepforyou]

[prepforyou]

有一群新竹泰雅族小朋友，想要飛到一個他們以為在世界地圖上才看得到的國家—— 德國，想要用自己的歌聲，站上國際舞台，讓世界聽見台灣的聲音，讓大家聽見他們泰雅族的歌曲。這些小朋友必須自己想辦法，因為沒有經費，只能靠自己的力量，參加全球知名的德國韋爾尼格羅德合唱比賽，但旅費還苦無著落，想把台灣原民歌聲帶到世界的夢想，請您與我ㄧ起聽一聽他們充滿感情的泰雅族歌曲，一起送他們去德國，讓世界聽見泰雅，認識台灣，好嗎？

購買桃山國小專輯《迴響 霞喀羅溪畔》

【專輯試聽】https://youtu.be/5gT2d66gu4s

【訂購網址】https://goo.gl/forms/pcZNrZ6koiQhsjLt2

★直接捐款，贊助孩子們出國比賽

【捐款網址】https://goo.gl/forms/yrZwn6T4Y8MAawgo2

[prepforyou]

「U=U」講給你長知識！

2016年（前）即有研究顯示，穩定接受抗病毒治療 (Antiretroviral Therapy，ART) 的愛滋感染者，其血液中的病毒量若持續六個月以上控制在測不到的狀態時，傳播HIV病毒的風險是可忽略，甚至不存在的 (negligible to non-existent) 。

「U=U」確認感染者也可以擁有健康的性生活，不只是科學實驗的結論，更是世界去愛滋污名的口號！

#雞尾酒療法藥物提升健康水平與壽命

#U等於U防疫與治癒的一大步

#測不到等於得不到 #UequalsU

[prepforyou]

人遠了，就永遠找不回來了。心冷了，就也無法再恢復

相愛每一天

都是幸運

記得要好好珍惜

因為人遠了，就再也找不回來

因為心死了，就再也無法再恢復。

[prepforyou]

你今天PrEP 了嗎？

[prepforyou]

[prepforyou]

Cheated.

You told them you loved them. I don’t know how we can move past this. I don’t know how we can ever be the same. You spoke to them in ways you’ve never spoken to me and that hurts. It hurts so much and I am at a loss. I’m in so much pain you don’t understand why? You say it was all a lie and its me you really love inside. I’m left with tears, fears, what if you meant it to them too? I feel so cheated. Defeated.

[prepforyou]

[prepforyou]

Simple protection Talisman spell:

First cleanse the necklace you wish to make into your talisman, when you’re ready take the necklace and hold it in your power hand (your dominate hand.)

Vizualise a bright warm light around it. Next imagine a force field around you warding off evil.

Say: “I call upon the universe, to make this my protective charm. When ever I where it, I shall endure no harm.”

Imagine the light soaking into the necklace, and then you’re done!

[prepforyou]

2018年的7月，來自Partner2這個全球多國多中心研究的科學報告指出：

體內HIV病毒量穩定控制在測不到的感染者

在統計學推估最壞最壞的情況下

要與他的固定伴侶連續400年發生沒有戴套的性行為

才有可能將HIV傳染給對方

世界上沒有百分百或機率絕對為0的事情

但在感染者們與其伴侶發生77,000次無套性行為後

沒有人因這些「0病毒量」的感染者而感染HIV

也就是所謂的「0傳染」

因此我們可以說

當感染者體內HIV病毒量穩定測不到時

就不會因無套性行為傳染給其他人

#MakeLoveNotFear

#CPUproject #HEArT #新滋識

#UequalsU #TasP #HIV

#HIVprevention #HIVpreventioncombo

[prepforyou]

PrEP是？

所謂的PrEP，是透過在性愛前先行投藥，體內產生防護體。在沒有使用保險套因而有體液交換的性愛中，因為有藥物形成的防護體，即使HIV病毒進到體內，也無法生存，因此能有效地預防HIV病毒的感染

[prepforyou]

戴套 or 不戴套？

所謂的PrEP，是透過在性愛前先行投藥，體內產生防護體。在沒有使用保險套因而有體液交換的性愛中，因為有藥物形成的防護體，即使HIV病毒進到體內，也無法生存，因此能有效地預防HIV病毒的感染。這跟過去我們習以為常的，以戴套作為防護手段的方式不太一樣。因此在PrEP問世的時候，在美國有所謂的PrEP slut的說法，大概跟台灣萌萌說PrEP是約炮丸的意思差不多，就是覺得某些人淫亂又不愛戴套要浪費公衛資源，乖乖戴套很難嗎之類的。我想要說的是，乖乖戴套真的沒有想像中的容易。如果戴套真的這麼容易，HIV可能就不是一個這麼令人苦惱的問題。如果每個人都戴套才打砲，你跟我又是怎麼出現在這個世界上的呢？

[prepforyou]

Breaking news: Daily and on-demand PrEP both prevent HIV in Prévenir study: high adherence by gay Parisians

Breaking news: Daily and on-demand PrEP both prevent HIV in Prévenir study: high adherence by gay Parisians

24 July 2018. Related: Early access, Conference reports, Prevention and transmission, World AIDS 22 Amsterdam 2018.

Simon Collins, HIV i-Base

Interim results from the PREVENIR (“prevent”) study, presented by Jean-Michel Molina in a press conference and as a late-breaker oral abstract at the AIDS 2018 conference in Amsterdam, continue to show the high efficacy of PrEP. [1, 2]

No new HIV infections were reported when oral TDF/FTC was taken in either daily or on-demand dosing (only using PrEP when needed).

The study, predominantly in gay men, reported very high levels of adherence. This is an ongoing open label study that provided PrEP to all participants and also allowed participants to choose their dosing strategy when appropriate. Women and transgender people are only recommended to use daily dosing in order to achieve protective drug levels. Men in the study were able to use less frequent dosing and were also able to switch between dosing strategies during the study.

The three-year Prévenir study was designed to find out how PrEP was used outside of a randomised study and to look at whether PrEP would reduce new infections in a real-world setting.

Prévenir started in May 2017 and has already enrolled more than 1600 of the planned 3000 adults at 22 HIV centres in Paris. The study hypothesis is that this level of PrEP use should show a 15% reduction in new infections among gay men in the city. HIV, creatinine and STI testing is recommended every three months, but is flexible based on the decision of the treating doctor. Participants also provide anonymised confidential information including about their sexual activity, partner numbers and pattern of PrEP use.

Baseline characteristics so far include median age 36 years (IQR: 30 to 44), with approximately 8% aged between 18 to 25. Although the study aimed for 85% gay men, so far very few participants are either heterosexual (0.8%) or transgender (0.5%). Roughly half the participants are single, roughly half have previously used PrEP, and chemsex was also common (used by 40% within the previous year).

Roughly half the participants chose on-demand dosing, with the only significant baseline differences being that these people were having sex slightly more often and with a higher median number of partners (15 vs 10 in the previous 3 months, p<0.001).

So far, 1102 participants have reported having sex 2279 times (1088 vs 1191 times in daily vs on demand groups), with PrEP covering >95% vs 81% of these times, respectively. Adherence was defined as taking at least one dose before sex and one after, with a 24-hour window period allowed for each dose. Condom use was also reported for about 20% of times people had sex in both groups. This might show that when PrEP was missed in the on demand group, participants compensated by using condoms.

Mean follow-up time is 7 (SD +/– 4) months, with 443 vs 506 participant years of follow up (PYFU) in the daily vs on demand groups respectively.

The principal efficacy results are that there have been no new HIV diagnoses in either group, with HIV incidence at 0 and upper 95%CI of 0.8 vs 0.7 in daily vs on demand groups. Based on historical incidence of 9.1/100 PY in the IPERGAY study, Prévenir has already prevented 85 HIV infections.

Approximately 3% of participants have discontinued the study, but none were due to side effects. Acute viral hepatitis was reported in 11 people, with 7/11 cases of hepatitis C, with no difference between groups.

Over time there were few behaviour differences reported between arms, but a possible trend for participants in both groups to have slightly more sex, interestingly, with fewer partners.

Note: this report has been published before the main conference presentation because of the IAS policy of choosing to hold press conferences before rather than after the researchers have presented their full results.

The report is based on early press access to the presentation slides. The embargo was lifted at the start of the related press conference but this report will be updated, if appropriate, after the full presentation.

COMMENT

As well as adding to efficacy and safety data on PrEP, these early results show that gay men in Paris have high adherence levels and high retention in the study.

Similar to the UK IMPACT study, uptake by heterosexual and transgender communities is much less than for gay men whose PrEP awareness is already high.

Results on the impact of PrEP on HIV incidence in the Paris region are still pending.

References

AIDS 2018 press conference. Prévenir study results. Tuesday 24 July 2018. 9.00 am.

http://www.aids2018.org/Media-Centre/Resources/Press-programme

Molina J-M et al. Incidence of HIV-infection in the ANRS Prévenir study in Paris region with daily or on-demand PrEP with TDF/FTC. AIDS 2018, 23-27 July 2018, Amsterdam. Late breaker oral abstract WEAE0406LB.

http://programme.aids2018.org/Abstract/Abstract/13278

Links to other websites are current at date of posting but not maintained.

[prepforyou]

New videos on PEP and PrEP!

Education about HIV prevention is critical as we work to serve the communities disproportionately affected by HIV. 

What is PEP?

Learn more about PEP>> 

What is PrEP?

Learn more about PrEP>>